OPEN END TURBO PUT WARRANT - AMGEN | Delayed Deutsche Boerse AG 05:08:33 2024-06-10 EDT | ||
| 0.85 EUR | -1.16% |
|
| 3 months | -27.12% | ||
| 6 months | -28.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-10 | 0.85 | -1.16% |
| 24-06-07 | 0.86 | +2.38% |
| 24-06-06 | 0.84 | +1.20% |
| 24-06-05 | 0.83 | 0.00% |
| 24-06-04 | 0.83 | -2.35% |
Delayed Quote Deutsche Boerse AG
Last update June 10, 2024 at 05:08 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK9NFF |
| ISIN | DE000UK9NFF3 |
| Date issued | 2022-11-10 |
| Strike | 398.9 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.23 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.81 € |
|---|---|
| Lowest since issue | 0.7 € |
| Spread | 0.04 € |
| Spread % | 4.49% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
